« Back
Home /
Nivolumab

Nivolumab

€4,014.00

Excl. VAT

Item no.	HY-P9903-50mg
Manufacturer	MedChem Express
CASRN	946414-94-4
Amount	50 mg
Category	Antibodies Primary Antibodies
Type	Antibody Monoclonal
Specific against	other
Purity	99.63
Dry ice	Yes
Citations	[1]Wang C, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014 Sep;2(9):846-56.
Smiles	[Nivolumab]
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	BMS-936558; ONO-4538; MDX-1106
Similar products	946414-94-4
Available
Product Description	Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Manufacturers Applications	Cancer-programmed cell death
Molecular Weight	143599.09
Clinical Information	Launched
Solubility	H2O
Pathway	Immunology/Inflammation
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

Listprice: €4,014.00

Price: €4,014.00

available

Quantity:

Compare

Add to wishlist